Core Viewpoint - Jiangsu Kangzhong announced a total operating revenue of 320.53 million yuan for 2025, representing a year-on-year increase of 7.52%, primarily due to the promotion of new product conversion and market expansion [1] Financial Performance - Operating profit was -10.76 million yuan, total profit was -10.98 million yuan, and net profit attributable to shareholders was -7.10 million yuan, all significantly decreased compared to the same period last year [1] - The basic earnings per share were -0.08 yuan, a decrease of 0.28 yuan year-on-year [1] Asset and Equity Position - Total assets at the end of the reporting period were 982.51 million yuan, an increase of 1.61% year-on-year [1] - Equity attributable to shareholders was 849.90 million yuan, a decrease of 1.47% year-on-year [1]
康众医疗:2025年营收3.21亿元,净利润亏损710万元